Trial Profile
Phase II trial to investigate sonepcizumab in patients with cancer (neuroblastoma or prostate cancer).
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2010
Price :
$35
*
At a glance
- Drugs Sonepcizumab (Primary)
- Indications Neuroblastoma; Prostate cancer
- Focus Therapeutic Use
- 06 Aug 2010 New trial record